about
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors.NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
P50
Q34095630-6A70825A-C1A0-4AE5-950E-C38B6F778E5BQ34756505-AE28F5BF-91E9-4F2B-BED3-98C3F525418BQ35143479-00600961-06A6-415F-A578-4F665E8B136AQ35143490-FD97E530-BA19-4967-B471-1BA5533D7EA2Q35671227-320B3A40-A29E-437D-A7D3-C42073CB8F42Q38061177-869EB6B0-DB92-4870-8414-9682D70F726AQ38088354-528E2C3D-4465-4A48-838D-F346219D88F5
P50
name
Rebeqa Gunnarsson
@ast
Rebeqa Gunnarsson
@en
Rebeqa Gunnarsson
@es
Rebeqa Gunnarsson
@fr
Rebeqa Gunnarsson
@nl
type
label
Rebeqa Gunnarsson
@ast
Rebeqa Gunnarsson
@en
Rebeqa Gunnarsson
@es
Rebeqa Gunnarsson
@fr
Rebeqa Gunnarsson
@nl
prefLabel
Rebeqa Gunnarsson
@ast
Rebeqa Gunnarsson
@en
Rebeqa Gunnarsson
@es
Rebeqa Gunnarsson
@fr
Rebeqa Gunnarsson
@nl